5 European Projects Found
Searched on 125080 European Projects
FINISHED
Adverse Immune Signatures and their Prevention in Corneal Transplantation (VISICORT)
Start date: Apr 1, 2014, End date: Mar 31, 2019,
"Immune system response is the most complex barrier to long-term success of tissue transplants/implants from allogeneic and bio-artificial sources. While newly developed tissue transplant procedures are not yet performed frequently enough for robust analysis of adverse immune responses in humans, corneal transplantation (CT) is a well-established allogeneic tissue transplant with >100,000 full- an ...
Read Project
12
Partners Participants
FINISHED
Universal Influenza Vaccines Secured (UNISEC)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
UNISEC brings together a European consortium of 3 University partners, 5 National Health Institutes and 3 SMEs, all with leading expertise in influenza vaccine research and development, to work on promising recently developed concepts for a universal influenza vaccine. The consortium is exceptionally strong, interdisciplinary and intersectional in nature, and encompasses a unique combination of sc ...
Read Project
15
Partners Participants
FINISHED
Integration of Biology and Engineering into an Economical and Energy-Efficient 2G Bioethanol Biorefinery (PROETHANOL2G)
Start date: Nov 1, 2010, End date: Oct 31, 2014,
The European Union has set a 10 % mandatory target for the share of renewables (including biofuels) in transportation sector by 2020 in Europe.To achieve this goal sustainable biofuels from lignocellulosic biomass must deploy in Europe very soon since the competition between food vs. energy prevents further (significant) increase on the current first-generation biofuels already in the market. This ...
Read Project
10
Partners Participants
FINISHED
Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors (UROMOL)
Start date: Feb 1, 2008, End date: Jul 31, 2013,
"Bladder cancer is a recurrent and very prevalent cancer and it generates the highest cost per patient in Europe. New genomic methods have allowed identifying new markers with potential clinical application. However, due to the use of single-marker assays and poor study design, none of these markers has made it to the clinic. FGFR3 and PIK3CA mutations, expression profiles, and microsatellite alte ...
Read Project
8
Partners Participants
FINISHED
Genomic Instability in Cancer and Precancer (GENICA)
Start date: Jan 1, 2008, End date: Dec 31, 2010,
"Genomic instability is a characteristic of practically all human cancers. Recent results generated by members of this Consortium suggest that signs of genomic instability are evident from the very beginning of human cancer development, even in precancerous lesions. In these early lesions, the genomic instability affects primarily specific genomic loci, called common fragile sites. Because common ...
Read Project
